| Financial Year |
March 31 2023 |
| Monetary Funds |
708,561,874.08 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,042,585.92 |
| Accounts Receivable |
355,375,250.95 |
| Advances to Suppliers |
113,772,265.13 |
| Other Receivables |
14,216,987.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
610,656,690.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
304,065.66 |
| Total Current Assets |
2,085,809,416.76 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,764,622.68 |
| Investment Properties |
-- |
| Fixed Assetes |
177,240,038.10 |
| Under-construction Projects |
5,540,915.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
19,173,215.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
18,798,511.82 |
| Other Non-Current Assets |
104,995,789.45 |
| Sub-Total of Non-Current Assets |
330,194,215.83 |
| Total Assets |
2,416,003,632.59 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
132,718,565.91 |
| Accounts Payable |
142,028,536.01 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,386,605.58 |
| Taxes Payable |
26,477,555.23 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
2,633,677.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
43,774,427.71 |
| Sub-Total of Current Liabilities |
954,424,939.67 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,899,725.14 |
| Total Liabilities |
957,324,664.81 |
| Paid-In Capital(Or Share Stock) |
273,923,271.00 |
| Capital Surplus |
763,184,089.82 |
| Surplus Reserve |
48,079,637.75 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
372,523,977.09 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,458,678,967.78 |
| Owner's Equity（Stockholder's Equity） |
1,458,678,967.78 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,416,003,632.59 |
